قالب وردپرس درنا توس
Home / Health / Novavax says positive results from coronavirus vaccine trials

Novavax says positive results from coronavirus vaccine trials



The hospital likes this one. >>This is a story that we have been reporting closely, and the Gettersburg-based Novavax and its COVID-19 vaccine efforts are continuing. After being selected to participate in the WAP program of White House surgery, Novavax became the focus of the country and received $1.6 billion in research funding. In the US Centers for Disease Control and Prevention (CDC) Immunization Routines Conference Advisory Committee, when we made a conclusion, we discovered how the NOVAAX study is better. Doctors found that about 2 doses of vaccine dose, about 21 days per week. Common side effects include headaches. Fatigue and muscle weakness. Some similar results obtained in the second phase (still in progress) showed the same side effects, and there were more than two results. >>It verifies what we are doing. People believe that we have a good vaccine and need public support and support. As early as July, we had a conversation with JIM YOUNG, the chairman of NOVAAX, who showed great self-confidence in his team and was ready to put it into practice. >>In the United Kingdom, the United States and Mexico, when three separate phases are underway, by the end of this month, placebo-controlled studies will begin using two dosage methods. The goal is to test up to 30,000 adults of various age risk categories and races. It is expected that data from the three-phase test will appear in the early first quarter of 2021

. For a closer look at today’s CDC meeting, please visit WBALTV.COM and MOBILE APP LIVE IN

It is considered a leader in potential coronavirus vaccines, and the Gaithersburg-based company is seeing some positive results from early trials. Coronavirus update | Latest data from Maryland | Where to test || According to Novavax’s doctors at a meeting on Friday, they got some very positive results, and it looks like these results are twice 21 days apart Independent shooting is beneficial, and all of this is to keep people away from the hospital. After being selected to participate in the White House’s “Operation Twisting” and receiving $1.6 billion in research grants, it became the focus of national attention. Last Friday, at the immunization practice advisory committee meeting of the Centers for Disease Control and Prevention, we said that when the first phase of the conclusion was reached, doctors found that taking two doses of the vaccine 21 days apart is better than a single dose, and common side effects include headaches. , Fatigue and myalgia. The second phase, which is still in progress, also produced similar results-the results of the study showed the same side effects and again proved that two doses seemed better than one. “It confirms what we are doing. People think we have a good vaccine. “This needs to be supported and shown to the public. “Novavax chairman Jim Young said in July. In July, there were 11 news stories with Young that he was confident in his team, and it seemed to be about to happen. By the end of this month, it will be carried out in the UK, the US and Mexico A placebo-controlled study of the company will begin using a two-dose method, with the goal of testing up to 30,000 adults of different ages, risk categories, and races. Data from the Phase III trial is expected to appear as early as the first quarter of 2021 . To view the full conference, click here.

It is considered a leader in potential coronavirus vaccines, and the Gaithersburg-based company is seeing some positive results from early trials.

|| Coronavirus update| Latest data from Maryland| Where to test||

According to what Novavax’s doctors said at the meeting on Friday, they got some very positive results.

It now appears that two separate shots 21 days apart work well, all of which are to keep people away from the hospital.

Novavax was selected to participate in the White House’s “Operation Warp Speed” (Operation Warp Speed), and after receiving a $1.6 billion research grant, he became the focus of worldwide attention.

On Friday, at the immunization practice advisory committee meeting of the Centers for Disease Control and Prevention, we had a better understanding of Novavax’s research progress.

When the conclusion of the first phase was reached, doctors found that two doses of the vaccine 21 days apart were better than a single dose, and common side effects included headache, fatigue and myalgia. The second phase, which is still in progress, has produced some similar results-the results of the study showed the same side effects, and two doses seemed better than one.

Novavax chairman Jim Young said in July: “It confirms what we are doing. People think we have a good vaccine that needs to be supported and disclosed.”

In July, 11 pieces of news talked to Young. Young expressed great confidence in his team, and this idea seems to be realized soon.

When the United Kingdom, the United States and Mexico conduct separate Phase III studies at the end of this month, the placebo-controlled study will begin using the two-dose approach.

The goal is to test up to 30,000 adults of different ages, risk categories and races.

It is expected that the data of the third phase of the trial will be released as early as the first quarter of 2021.


Source link